Survival analysis, which incorporated scoring for CXCL16 and five signature genes specifically overexpressed in tumor cells, discovered a significant association between high CXCL16 expression and poor prognosis in GC patients (Figures 5D). The gene discussed is CXCL16; the disease is gastric cancer.